Carlos Jimenez – Managing Director, B. Braun Aesculap Mexico
Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum…
Address: Avenida Paseo del Pacifico No. 410, Technology Park, C.P. 45010, Carretera a Nogales km 13.5, Zapopan, Jalisco, México
,Mexico
Tel: +52 33 3777 4770
Web: http://www.gelpharma.com/
Gelpharma began operations in Mexico in 1999 as a high-tech pharmaceutical company; the result of the integration of 100% Mexican private capital. Focused primarily on the manufacturing of soft gelatin capsules under the strictest quality standards, Gelpharma has gained wide recognition in both the public and private sector. At present, Gelpharma has two soft gel manufacturing plants installed in Jocotán (Jalisco) and Guadalajara Technology Park, both equipped with the most advanced pharmaceutical technology, and thanks to its steady growth, has expanded distribution of its products to Central and South America.
High quality soft-gel capsules
Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum…
Brothers Juan José and Andrés Aguirre Salazar of Grupo Bruluart talk about the company’s most important milestones and how they are institutionalizing the family business to prepare the firm for…
Clinical research and access are the name of the game. The Executive Director of the association bringing together the most important research-based pharmaceutical companies discusses how the association has stepped…
The genomic revolution represents a before and after in the field of medicine. Sistemas Genómicos has understood this back in 1998 and today is the largest private organization offering DNA…
The general manager for Cegedim Mexico, Central America and the Caribbean discusses how the company is diversifying its product portfolio to tap into new business segments and attend new clients…
Boehringer Ingelheim is turning 130 in 2015. Miguel Salazar, president and country managing director for Mexico, explains how he is steering the company to bypass the currents of the ever-changing…
‘Health is the milestone of any society’. The former minister of health and former dean of Mexico’s most important university discusses the vision behind the creation of thought-leading institutions such…
Besides protecting the health of Mexicans, COFEPRIS today offers an important value-added to the investment community: predictability. The organization’s commissioner shares the astonishing results of his last three years of…
Biograft is the first private tissue bank in Mexico meeting the increasing demand for implants of human musculoskeletal tissue. The general director and founder discusses the vision behind the creation…
Merck is getting “Fit for 2018”. Pedro Galvis, the company’s managing director for Mexico, discusses how the company’s transformation program, implemented in 2012, is ensuring future growth and how Mexico’s…
Novo Nordisk’s market access and public affairs director discusses the state of diabetes management in Mexico, highlighting the government’s recent commitment to tackle this public health issue and the company’s…
Alejandro Luna and José Alfredo Sedano, lawyers at the leading legal firm of Santamarina y Steta, discuss the current legal challenges faced by companies in the pharmaceutical and healthcare sector…
See our Cookie Privacy Policy Here
